INDUCTION OF CUTANEOUS GRAFT-VERSUS-HOST DISEASE BY LOCAL INJECTION OF UNPRIMED T-CELLS

被引:0
作者
KAWAI, K [1 ]
MATSUMOTO, Y [1 ]
WATANABE, H [1 ]
ITO, M [1 ]
FUJIWARA, M [1 ]
机构
[1] NIIGATA UNIV,SCH MED,DEPT DERMATOL,NIIGATA 951,JAPAN
关键词
GRAFT-VERSUS-HOST DISEASE; CUTANEOUS LESIONS; MHC; T-CELL SUBSETS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The skin is a major target organ in human graft-versus-host disease (GVHD) after bone-marrow transplantation. GVHD can be induced in mice by i.v. injection of T cells into unirradiated semiallogeneic or lethally irradiated allogeneic recipients. However, in the murine systemic GVHD model, cutaneous lesions occur only in lethally irradiated recipients. Since lethal irradiation itself might induce the epidermal cell damage, several investigators have employed another murine model of cutaneous GVHD, in which cutaneous lesions were induced by intradermal injection of alloreactive T cell clones. Using this system, it has been reported that both MHC class I- and II-reactive T cell clones can induce cutaneous GVHD in non-irradiated or sublethally irradiated recipients. However, it has remained unknown whether or not freshly prepared T cells are able to induce cutaneous GVHD after local injection into non-irradiated recipients. We show that unprimed T cells can induce cutaneous GVHD after local injection into unirradiated MHC class II- or I + II-disparate recipients. In contrast to alloreactive T cell clones, unprimed T cells could elicit only mild cutaneous lesions in MHC class I-disparate recipients. Since sublethal irradiation of MHC class I-disparate recipients did not result in the manifestation of cutaneous lesions after injection of unprimed T cells, host anti-donor responses by radiosensitive cells could not be responsible for this phenomenon. This experimental system provides a useful model for analysis of the regulation mechanisms in the induction of GVHD by unprimed T cells.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 27 条
[11]  
LERNER KG, 1974, TRANSPLANT P, V6, P367
[12]  
LIU M, 1990, J IMMUNOL, V144, P41
[13]   B6.C-H-2BM12 - NEW H-2 MUTATION IN THE I-REGION IN THE MOUSE [J].
MCKENZIE, IFC ;
MORGAN, GM ;
SANDRIN, MS ;
MICHAELIDES, MM ;
MELVOLD, RW ;
KOHN, HI .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (06) :1323-1338
[14]  
MURPHY WJ, 1990, J IMMUNOL, V144, P3305
[15]  
MUTO M, 1983, CANCER RES, V43, P3822
[16]  
PIQUET PF, 1987, J IMMUNOL, V139, P406
[17]  
RAPPAPORT H, 1979, AM J PATHOL, V96, P121
[18]   ALLOSUPPRESSOR AND ALLOHELPER T-CELLS IN ACUTE AND CHRONIC GRAFT-VS-HOST DISEASE .2. F1 RECIPIENTS CARRYING MUTATIONS AT H-2K AND OR I-A [J].
ROLINK, AG ;
PALS, ST ;
GLEICHMANN, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (02) :755-771
[19]  
SHINOHARA N, 1984, J IMMUNOL, V132, P578
[20]   INDUCTION OF CUTANEOUS GRAFT-VERSUS-HOST DISEASE BY ALLOREACTIVE OR SELF-IA-REACTIVE HELPER T-CELLS IN MICE [J].
SHIOHARA, T ;
NARIMATSU, H ;
NAGASHIMA, M .
TRANSPLANTATION, 1987, 43 (05) :692-698